Basic & Translational Research

A ‘landmark’ study, over 100 IOP-associated genetic variants, and the future of glaucoma care.

Introducing the recipient of the inaugural ICO-Allergan Advanced Research Fellowship.

New immunotherapies have radically changed cancer care – what off-target effects should ophthalmologists look out for?

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

A burst of color shows a retinal organoid in all its glory.

How Seva plans to add another million sight-saving surgeries in developing countries per year by 2020.

Simpler to produce and easier to administer than stem cell therapies – are exosomes the answer to our retinal regeneration needs?

Reprogramming cells to sidestep disease – or turning back the clock on senescent cells in age-related disease? Here’s what we can do today – and what’s on the horizon.

Might temporary microglia depletion treat inflammatory retinal disease?

Is gene therapy the answer to an untreatable form of macular degeneration?